First American Bank decreased its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 44.9% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,447 shares of the semiconductor company’s stock after selling 1,996 shares during the period. First American Bank’s holdings in Synopsys were worth $1,207,000 as of its most recent SEC filing.
A number of other hedge funds have also recently made changes to their positions in SNPS. Symphony Financial Ltd. Co. grew its holdings in shares of Synopsys by 4,780.9% in the second quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock worth $20,638,000 after acquiring an additional 39,395 shares during the period. HBW Advisory Services LLC boosted its position in Synopsys by 494.9% in the second quarter. HBW Advisory Services LLC now owns 3,611 shares of the semiconductor company’s stock worth $1,851,000 after purchasing an additional 3,004 shares during the last quarter. Bank of New York Mellon Corp grew its stake in shares of Synopsys by 0.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock valued at $691,035,000 after purchasing an additional 4,815 shares during the period. Westbourne Investments Inc. purchased a new stake in shares of Synopsys during the 2nd quarter valued at about $1,505,000. Finally, Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Synopsys by 1.7% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 178,786 shares of the semiconductor company’s stock worth $91,660,000 after purchasing an additional 2,991 shares during the period. 85.47% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several analysts recently issued reports on the stock. KeyCorp boosted their target price on shares of Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Citigroup assumed coverage on shares of Synopsys in a research report on Monday, November 24th. They set a “buy” rating and a $580.00 price objective for the company. Baird R W cut Synopsys from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 10th. Mizuho cut their price target on Synopsys from $700.00 to $600.00 and set an “outperform” rating for the company in a report on Thursday, September 11th. Finally, Wells Fargo & Company upped their price target on Synopsys from $445.00 to $500.00 and gave the stock an “equal weight” rating in a research report on Thursday, December 11th. Eleven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Synopsys has a consensus rating of “Moderate Buy” and a consensus price target of $562.13.
Insiders Place Their Bets
In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This trade represents a 17.01% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.62% of the stock is owned by insiders.
Synopsys Trading Up 0.4%
Shares of Synopsys stock opened at $478.97 on Tuesday. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. The company has a market capitalization of $91.64 billion, a P/E ratio of 59.95, a P/E/G ratio of 3.97 and a beta of 1.16. The company has a fifty day moving average of $438.09 and a 200 day moving average of $503.51.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.79 by $0.11. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The business’s revenue was up 37.8% on a year-over-year basis. During the same period in the previous year, the business earned $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, sell-side analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- Wall Street Stockpicker Names #1 Stock of 2026
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Your “birthright claim” just got activated
- Buy this $2 Gold Stock Before January 1, 2026
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
